SG11201909170QA - Thermogelling artificial tears - Google Patents
Thermogelling artificial tearsInfo
- Publication number
- SG11201909170QA SG11201909170QA SG11201909170QA SG11201909170QA SG 11201909170Q A SG11201909170Q A SG 11201909170QA SG 11201909170Q A SG11201909170Q A SG 11201909170QA SG 11201909170Q A SG11201909170Q A SG 11201909170QA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- artificial tears
- present
- thermogelling
- thermogelling artificial
- Prior art date
Links
- 239000000607 artificial tear Substances 0.000 title 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 abstract 1
- 238000001879 gelation Methods 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017086512 | 2017-04-25 | ||
| JP2017249891 | 2017-12-26 | ||
| PCT/JP2018/016854 WO2018199180A1 (ja) | 2017-04-25 | 2018-04-25 | 熱ゲル化人工涙液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201909170QA true SG11201909170QA (en) | 2019-11-28 |
Family
ID=63919901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201909170Q SG11201909170QA (en) | 2017-04-25 | 2018-04-25 | Thermogelling artificial tears |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10532026B2 (https=) |
| EP (1) | EP3593806B1 (https=) |
| JP (2) | JP6473274B1 (https=) |
| KR (2) | KR102281853B1 (https=) |
| CN (2) | CN110913867B (https=) |
| AU (1) | AU2018257301B2 (https=) |
| BR (1) | BR112019018368B1 (https=) |
| CA (1) | CA3025567C (https=) |
| ES (1) | ES2912289T3 (https=) |
| MX (2) | MX379302B (https=) |
| MY (2) | MY196565A (https=) |
| PH (1) | PH12019502335A1 (https=) |
| RU (1) | RU2710366C1 (https=) |
| SG (1) | SG11201909170QA (https=) |
| TW (1) | TWI733019B (https=) |
| WO (1) | WO2018199180A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117137866A (zh) * | 2018-02-28 | 2023-12-01 | 参天制药株式会社 | 含有地夸磷索及阳离子性聚合物的眼科用组合物 |
| AU2019228913C1 (en) * | 2018-03-01 | 2024-10-31 | Ishihara Sangyo Kaisha, Ltd. | Pharmaceutical composition with excellent storage stability |
| ES2994624T3 (en) * | 2019-02-27 | 2025-01-27 | Santen Pharmaceutical Co Ltd | Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2125060C (en) * | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
| JP3450805B2 (ja) | 2000-08-08 | 2003-09-29 | わかもと製薬株式会社 | 水性医薬組成物 |
| JP2003095924A (ja) * | 2001-07-16 | 2003-04-03 | Wakamoto Pharmaceut Co Ltd | 熱ゲル化人工涙液 |
| GB0210794D0 (en) * | 2002-05-10 | 2002-06-19 | Chart Heat Exchangers Ltd | Heat exchangers |
| JP4263456B2 (ja) | 2002-03-18 | 2009-05-13 | わかもと製薬株式会社 | ヒアルロン酸含有熱ゲル化製剤 |
| JP4263418B2 (ja) * | 2002-03-18 | 2009-05-13 | わかもと製薬株式会社 | 熱ゲル化人工涙液 |
| JP4947977B2 (ja) | 2003-10-31 | 2012-06-06 | わかもと製薬株式会社 | 可逆性熱ゲル化水性組成物 |
| JP5649261B2 (ja) * | 2004-05-07 | 2015-01-07 | ロート製薬株式会社 | 高粘度点眼剤 |
| JP5661981B2 (ja) * | 2004-11-26 | 2015-01-28 | 大正製薬株式会社 | 眼科用剤 |
| EP2172224A4 (en) * | 2007-06-26 | 2013-01-16 | Wakamoto Pharma Co Ltd | AQUEOUS COMPOSITION |
-
2018
- 2018-04-25 RU RU2019123442A patent/RU2710366C1/ru active
- 2018-04-25 KR KR1020207004982A patent/KR102281853B1/ko not_active Expired - Fee Related
- 2018-04-25 BR BR112019018368-0A patent/BR112019018368B1/pt not_active IP Right Cessation
- 2018-04-25 CN CN201880026982.8A patent/CN110913867B/zh not_active Expired - Fee Related
- 2018-04-25 SG SG11201909170Q patent/SG11201909170QA/en unknown
- 2018-04-25 WO PCT/JP2018/016854 patent/WO2018199180A1/ja not_active Ceased
- 2018-04-25 MY MYPI2019006324A patent/MY196565A/en unknown
- 2018-04-25 MX MX2019015717A patent/MX379302B/es unknown
- 2018-04-25 MY MYPI2021001185A patent/MY196323A/en unknown
- 2018-04-25 MX MX2018014935A patent/MX2018014935A/es active IP Right Grant
- 2018-04-25 TW TW107114359A patent/TWI733019B/zh active
- 2018-04-25 ES ES18790126T patent/ES2912289T3/es active Active
- 2018-04-25 KR KR1020197026971A patent/KR102083253B1/ko not_active Expired - Fee Related
- 2018-04-25 CN CN202110681026.7A patent/CN113332233B/zh not_active Expired - Fee Related
- 2018-04-25 AU AU2018257301A patent/AU2018257301B2/en not_active Ceased
- 2018-04-25 CA CA3025567A patent/CA3025567C/en active Active
- 2018-04-25 JP JP2018527825A patent/JP6473274B1/ja active Active
- 2018-04-25 EP EP18790126.9A patent/EP3593806B1/en active Active
- 2018-08-23 US US16/110,056 patent/US10532026B2/en active Active
-
2019
- 2019-01-24 JP JP2019010213A patent/JP6736705B2/ja active Active
- 2019-10-14 PH PH12019502335A patent/PH12019502335A1/en unknown
- 2019-12-17 US US16/717,004 patent/US11096889B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL307911B1 (en) | Heterocyclic derivatives, medicinal preparations containing them and their use as medicines. | |
| MX382534B (es) | Composicion oftalmologica | |
| WO2016178586A3 (en) | Collagen compositions and preparation and uses thereof | |
| ZA201902053B (en) | Pharmaceutical composition | |
| HRP20241734T1 (hr) | Pripravak za uporabu u prevenciji ili suzbijanju miopije | |
| PH12015501957A1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| PH12015502013A1 (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| EP2996172A3 (en) | Biocompatibility of biomedical energization elements | |
| BR112018075140A2 (pt) | composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8 | |
| WO2015120231A3 (en) | Stable peptide formulations and methods for preparation | |
| EP4327880A3 (en) | Solid state form of ribociclib succinate | |
| EP4674271A3 (en) | Encapsulation of high potency active agents | |
| SG11201909170QA (en) | Thermogelling artificial tears | |
| MX2016001834A (es) | Sal hemisulfato de acido 5,10-metilen-(6r)-tetrahidrofolico. | |
| MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
| MY173573A (en) | Pyridin-4-yl derivatives | |
| ZA202108987B (en) | 1-amino-1-cyclopropanecarboxylic acid hudrochloride formulations | |
| PL3714011T3 (pl) | Wodna kompozycja i wodny środek powłokowy | |
| MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
| MX2019010218A (es) | Derivados de pirazol como inhibidores de bromodominio. | |
| BR112017020216A2 (pt) | ?composição aquosa?. | |
| PH12021550090A1 (en) | Composition comprising glycyrrhizin and cosmetic and pharmaceutical uses thereof | |
| WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
| PH12019502696A1 (en) | Resorbable biodegradable medical and cosmetic composition comprising poly(1,3-trimethylene carbonate) | |
| GEP20196957B (en) | Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations |